Alkermes Public Limited Company于2011年5月4日在爱尔兰成立为一家私人有限公司，名称为Antler Science Two Limited（注册号498284）。该公司是一家完全整合的全球性生物制药公司，利用其科学专长和专有技术开发创新药物，改善患者的治疗效果。公司拥有多元化的产品组合，包括20多种商业药物产品和大量临床候选产品，用于治疗中枢神经系统疾病，如成瘾、精神分裂症和抑郁症。
董事
名称
职位
Richard F. Pops
Chairman,Chief Executive Officer
Brian P. McKeon
Director
David A. Daglio, Jr.
Director
David W. Anstice
Director
Frank Anders Wilson
Director
Nancy J. Wysenski
Director
Nancy L. Snyderman
Director
Richard B. Gaynor
Director
Shane Cooke
Director
Wendy L. Dixon
Director
股东
名称
职位
Richard F. Pops
Chairman,Chief Executive Officer
Blair C. Jackson
Executive Vice President, Chief Operating Officer
C. Todd Nichols
Senior Vice President, Chief Commercial Officer
David J. Gaffin
Senior Vice President, Chief Legal Officer and Chief Compliance Officer
Iain M. Brown
Senior Vice President, Chief Financial Officer
Michael J. Landine
Senior Vice President, Corporate Development and Chief Risk Officer
Craig C. Hopkinson
Executive Vice President, Research and Development and Chief Medical Officer